/5
0 avis
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies
Archive ouverte
Edité par CCSD ; Ferrata Storti Foundation -
International audience
Consulter en ligne
Chargement des enrichissements...